|
DCOY Decoy Therapeutics Inc 1615219 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-2,224,628.00 |
| Balance Sheet |
|
Current Assets
|
$8,357,652.00 |
|
Assets
|
$8,423,275.00 |
|
Current Liabilities
|
$4,545,890.00 |
|
Liabilities
|
$4,545,890.00 |
|
Equity
|
$3,877,385.00 |
|
Shares Out
|
531968.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,889,329.00 |
|
Investing Cash Flow
|
$764,735.00 |
| Market Analysis |
Market Cap
|
$2,085,314.56 |
|
Price
|
$4.43 |
|
BVPS
|
7.29 |
|
PB
|
0.54 |
|
EPS
|
-4.18 |
|
FCF
|
$-3,466,329.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:48 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DCOY documents filed with the SEC.
DCOY Filings
Clear
